The 10-second takeaway
For the quarter ended March 31 (Q1), Sanofi met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue improved slightly and GAAP earnings per share expanded significantly.
Gross margins contracted, operating margins improved, and net margins improved.
Sanofi logged revenue of $11.35 billion. The 12 analysts polled by S&P Capital IQ foresaw revenue of $11.48 billion on the same basis. GAAP reported sales were 2.5% higher than the prior-year quarter's $11.62 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $2.47. The eight earnings estimates compiled by S&P Capital IQ averaged $2.23 per share. GAAP EPS of $1.84 for Q1 were 39% higher than the prior-year quarter's $1.32 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 70.6%, 50 basis points worse than the prior-year quarter. Operating margin was 26.0%, 20 basis points better than the prior-year quarter. Net margin was 20.4%, 550 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $11.52 billion. On the bottom line, the average EPS estimate is $1.90.
Next year's average estimate for revenue is $45.86 billion. The average EPS estimate is $7.71.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Sanofi is outperform, with an average price target of $81.64.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Sanofi. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Sanofi to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.